An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023.Brendan McDermid | ReutersCompanies are increasing access to new blockbuster weight-loss drugs for employees, but size of employer may make a big difference in...
